25 April, 2022
Today we want to present you the current work in the iPC project of our partner LMU!
Within the fourth year of the iPC project, LMU has started to test drugs identified within the iPC consortium in combination with the standard-of-care therapeutics for pediatric liver cancers.
Once we have identified synergies between drugs, they might be used as a replacement for conventional chemotherapy, which could not only improve patients’ outcome, but also reduce severe long-term side effects.
